Region-Specific Effects of Trigeminal Capsaicin Stimulation

Aims: To investigate the region-specific effects of painful trigeminal capsaicin stimulation in healthy participants. Methods: Twenty healthy participants (10 men and 10 women) participated in four sessions in which they received application of 0.05 mL Vaseline (placebo) or capsaicin cream (0.1%) to a different area innervated by the three branches of the trigeminal nerve: the supraorbital area (V1), the nasal mucosa (V1/V2), and the maxillary (V2) and mandibular (V3) oral mucosa. The participants rated their perceived sensations on a 0-50-100 numeric rating scale (NRS). Thermal (5°C, 23°C, and 50°C) and mechanical (32 mN and 256 mN) sensitivities were assessed. The Schirmer tearing test was used to monitor the lacrimation level as a local measure of autonomic activity, and the Task Force Monitor was used to record systemic autonomic activity. Data were analyzed using repeated measures analysis of variance. Results: Capsaicin application evoked significantly higher overall NRS scores (P < .001) and induced significantly higher ratings to the heat stimuli (P < .009) in all sessions compared to control. For lacrimation level, capsaicin stimulation resulted in a significant increase compared to control (P < .0002) only in the nasal mucosa session. Conclusion: Topical application of capsaicin cream to the different branches of the trigeminal nerve caused higher NRS scores along with an altered somatosensory sensitivity. Furthermore, in the nasal mucosa session, a robust local and generalized parasympathetic activation appeared following capsaicin application.

autonomic nervous system; capsaicin, experimental pain model; trigeminal nociception; trigeminal parasympathetic reflex

1. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013;33:629–808.

2. Fischera M, Marziniak M, Gralow I, Evers S. The incidence and prevalence of cluster headache: A meta-analysis of popula-tion-based studies. Cephalalgia 2008;28:614–618.

3. Goadsby PJ. Pathophysiology of cluster headache: A trigemi-nal autonomic cephalgia. Lancet Neurol 2002;1:251–257.

4. Frese A, Evers S, May A. Autonomic activation in experimental trigeminal pain. Cephalalgia 2003;23:67–68.

5. Stankewitz A, Voit HL, Bingel U, Peschke C, May A. A new tri-gemino-nociceptive stimulation model for event-related fMRI. Cephalalgia 2010;30:475–485.

6. Modir JG, Wallace MS. Human experimental pain models 3: Heat/capsaicin sensitization and intradermal capsaicin mod-els. Methods Mol Biol 2010;617:169–174.

7. Flühr K, Neddermeyer TJ, Lötsch J. Capsaicin or menthol sensitization induces quantitative but no qualitative chang-es to thermal and mechanical pain thresholds. Clin J Pain 2009;25:128–131.

8. Kennedy WR, Vanhove GF, Lu SP, et al. A randomized, con-trolled, open-label study of the long-term effects of NGX-4010, a high-concentration capsaicin patch, on epidermal nerve fiber density and sensory function in healthy volunteers. J Pain 2010;11:579–587.

9. Konietzny F, Hensel H. The effect of capsaicin on the response characteristic of human C-polymodal nociceptors. J Thermal Bio 1983;213–215.

10. Liu M, Max MB, Robinovitz E, Gracely RH, Bennett GJ. The hu-man capsaicin model of allodynia and hyperalgesia: Sources of variability and methods for reduction. J Pain Symptom Manage 1998;16:10–20.

11. Magerl W, Fuchs PN, Meyer RA, Treede RD. Roles of capsa-icin-insensitive nociceptors in cutaneous pain and secondary hyperalgesia. Brain 2001;124:1754–1764.

12. Thygesen TH, Nørholt SE, Jensen J, Svensson P. Spatial and temporal assessment of orofacial somatosensory sensitivity: A methodological study. J Orofac Pain 2007;21:19–28.

13. Lu S, Svensson P, Zhang Z, List T, Baad-Hansen L. Effect of experimental periodontal ligament pain on gingival somatosen-sory sensitivity. J Oral Facial Pain Headache 2017;31:72–79.

14. Lu S, Baad-Hansen L, Zhang Z, Svensson P. Spatial and tem-poral effects of capsaicin and menthol on intraoral somatosen-sory sensitivity. J Oral Facial Pain Headache 2015;29:257–264.

15. Lu S, Baad-Hansen L, List T, Zhang Z, Svensson P. Somato-sensory profiling of intra-oral capsaicin and menthol in healthy subjects. Eur J Oral Sci 2013;121:29–35.

16. Boudreau SA, Wang K, Svensson P, Sessle BJ, Arendt-Nielsen L. Vascular and psychophysical effects of topical capsaicin application to orofacial tissues. J Orofac Pain 2009;23:253–264.

17. Baad-Hansen L, Jensen TS, Svensson P. A human model of intraoral pain and heat hyperalgesia. J Orofac Pain 2003;17: 333–340.

18. Naganawa T, Baad-Hansen L, Ando T, Svensson P. Influence of topical application of capsaicin, menthol and local anes-thetics on intraoral somatosensory sensitivity in healthy sub-jects: Temporal and spatial aspects. Exp Brain Res 2015;233: 1189–1199.

19. Martins IP, Gouveia RG, Parreira E. Cluster headache with-out autonomic symptoms: Why is it different? Headache 2005;45:190–195.

20. Torelli P, Cologno D, Cademartiri C, Manzoni GC. Application of the International Headache Society classification criteria in 652 cluster headache patients. Cephalalgia 2001;21:145–150.

21. Benoliel R, Elishoov H, Sharav Y. Orofacial pain with vascu-lar-type features. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;84:506–512.

22. Peñarrocha M, Bandrés A, Peñarrocha M, Bagán JV. Lower-half facial migraine: A report of 11 cases. J Oral Maxillofac Surg 2004;62:1453–1456.

23. Svensson P, Graven-Nielsen T, Arendt-Nielsen L. Mechanical hyperesthesia of human facial skin induced by tonic painful stimulation of jaw muscles. Pain 1998;74:93–100.

24. Naganawa T, Baad-Hansen L, Iida T, Ando T, Svensson P. Assessment of human intraoral thermal sensitivity with simple devices in the clinic: Implications for orofacial pain conditions. J Oral Facial Pain Headache 2015;29:83–90.

25. Rolke R, Baron R, Maier C, et al. Quantitative sensory testing in the German Research Network on Neuropathic Pain (DFNS): Standardized protocol and reference values. Pain 2006;123: 231–243.

26. Mücke M, Cuhls H, Radbruch L, et al. Quantitative sensory testing (QST). English version. Schmerz 2016. Epub ahead of print Jan 29.

27. Simpson DM, McArthur JC, Dworkin RH. Neuropathic Pain: Mechanisms, Diagnosis, and Treatment. New York: Oxford University, 2012.

28. Karampatakis V, Karamitsos A, Skriapa A, Pastiadis G. Comparison between normal values of 2- and 5-minute Schirmer test without anesthesia. Cornea 2010;29:497–501.

29. Serin D, Karslog˘lu S, Kyan A, Alagöz G. A simple approach to the repeatability of the Schirmer test without anesthesia: Eyes open or closed? Cornea 2007;26:903–906.

30. Millodot M. Dictionary of Optometry and Visual Science, ed 7. London: Elsevier, 2009.

31. Heart rate variability: Standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Circulation 1996;93: 1043–1065.

32. Terkelsen AJ, Mølgaard H, Hansen J, Finnerup NB, Krøner K, Jensen TS. Heart rate variability in complex regional pain syndrome during rest and mental and orthostatic stress. Anesthesiology 2012;116:133–146.

33. Kilo S, Schmelz M, Koltzenburg M, Handwerker HO. Different patterns of hyperalgesia induced by experimental inflammation in human skin. Brain 1994;117:385–396.

34. Caterina MJ, Schumacher MA, Tominaga M, Rosen TA, Levine JD, Julius D. The capsaicin receptor: A heat-activated ion channel in the pain pathway. Nature 1997;389:816–824.

35. Petersen KL, Rowbotham MC. A new human experimental pain model: The heat/capsaicin sensitization model. Neuroreport 1999;10:1511–1516.

36. Ngom PI, Dubray C, Woda A, Dallel R. A human oral capsa-icin pain model to assess topical anesthetic-analgesic drugs. Neurosci Lett 2001;316:149–152.

37. LaMotte RH, Lundberg LE, Torebjörk HE. Pain, hyperalgesia and activity in nociceptive C units in humans after intradermal injection of capsaicin. J Physiol 1992;448:749–764.

38. Rolke R, Magerl W, Campbell KA, et al. Quantitative sensory testing: A comprehensive protocol for clinical trials. Eur J Pain 2006;10:77–88.

39. Simone DA, Nolano M, Johnson T, Wendelschafer-Crabb G, Kennedy WR. Intradermal injection of capsaicin in humans produces degeneration and subsequent reinnervation of epidermal nerve fibers: Correlation with sensory function. J Neurosci 1998;18:8947–8959.

40. Jürgens TP, May A. Role of sphenopalatine ganglion stimulation in cluster headache. Curr Pain Headache Rep 2014;18:433.

41. Leone M, Proietti Cecchini A. Advances in the understanding of cluster headache. Expert Rev Neurother 2017;17:165–172.

42. Gazerani P, Andersen OK, Arendt-Nielsen L. A human experimental capsaicin model for trigeminal sensitization. Gender-specific differences. Pain 2005;118:155–163.

43. Frot M, Feine JS, Bushnell MC. Sex differences in pain perception and anxiety. A psychophysical study with topical cap-saicin. Pain 2004;108:230–236.

44. Gazerani P, Andersen OK, Arendt-Nielsen L. Site-specific, dose-dependent, and sex-related responses to the experimental pain model induced by intradermal injection of capsaicin to the foreheads and forearms of healthy humans. J Orofac Pain 2007;21:289–302.

45. Wagner H, Fink BA, Zadnik K. Sex- and gender-based differences in healthy and diseased eyes. Optometry 2008;79: 636–652.

46. Sakamoto R, Bennett ES, Henry VA, et al. The phenol red thread tear test: A cross-cultural study. Invest Ophthalmol Vis Sci 1993;34:3510–3514.

47. Schaller B, Probst R, Strebel S, Gratzl O. Trigeminocardiac reflex during surgery in the cerebellopontine angle. J Neurosurg 1999;90:215–220.

48. McCulloch PF, Faber KM, Panneton WM. Electrical stimulation of the anterior ethmoidal nerve produces the diving response. Brain Res 1999;830:24–31.

49. Dutschmann M, Herbert H. The Kölliker-Fuse nucleus mediates the trigeminally induced apnoea in the rat. Neuroreport 1996;7:1432–1436.

50. Chowdhury T, Mendelowith D, Golanov E, et al. Trigeminocardiac reflex: The current clinical and physiological knowledge. J Neurosurg Anesthesiol 2015;27:136–147.

51. Karrer T, Bartoshuk L. Capsaicin desensitization and recovery on the human tongue. Physiol Behav 1991;49:757–764.

52. Savini G, Prabhawasat P, Kojima T, Grueterich M, Espana E, Goto E. The challenge of dry eye diagnosis. Clin Ophthalmol 2008;2:31–55.

53. Schytz HW, Barløse M, Guo S, et al. Experimental activation of the sphenopalatine ganglion provokes cluster-like attacks in humans. Cephalalgia 2013;33:831–841.

54. Guo S, Petersen AS, Schytz HW, et al. Cranial parasympathetic activation induces autonomic symptoms but no cluster headache attacks. Cephalalgia 2018;38:1418–1428.

55. Senchyna M, Wax MB. Quantitative assessment of tear production: A review of methods and utility in dry eye drug discovery. J Ocul Biol Dis Infor 2008;1:1–6.

56. Pearce EI, Keenan BP, McRory C. An improved fluorophotometric method for tear turnover assessment. Optom Vis Sci 2001;78:30–36.

57. Squier CA, Lesch CA. Penetration pathways of different compounds through epidermis and oral epithelia. J Oral Pathol 1988;17:512–516.

58. Squier CA, Hall BK. The permeability of skin and oral mucosa to water and horseradish peroxidase as related to the thickness of the permeability barrier. J Invest Dermatol 1985;84:176–179.

59. Wertz PW, Squier CA. Cellular and molecular basis of barrier function in oral epithelium. Crit Rev Ther Drug Carrier Syst 1991;8:237–269.